Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2020 3
2021 1
2022 6
2023 4
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum.
Hughes R, Rapsomaniki E, Bansal AT, Vestbo J, Price D, Agustí A, Beasley R, Fageras M, Alacqua M, Papi A, Müllerová H, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Hughes R, et al. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2803-2811. doi: 10.1016/j.jaip.2023.05.013. Epub 2023 May 23. J Allergy Clin Immunol Pract. 2023. PMID: 37230383 Free article.
Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.
Bravo-Gutiérrez FJ, Miralles-López JC, Valverde-Molina J, Alemany Francés ML, Andújar-Espinosa R, Castilla-Martínez M, Avilés-Inglés MJ, Mora-González A, Pajarón-Fernández MJ, Cabrejos-Perotti S, Meseguer-Arce J, Flores Martín I, Pérez-Fernández V; RE-ASGRAMUR Group. Bravo-Gutiérrez FJ, et al. Among authors: castilla martinez m. Int Arch Allergy Immunol. 2024;185(3):253-259. doi: 10.1159/000534902. Epub 2023 Nov 30. Int Arch Allergy Immunol. 2024. PMID: 38035559
[Consensus document for severe asthma in adults. 2022 update].
Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, Martínez-Moragon E, Muñoz X, Padilla-Galo A, Perpiñá-Tordera M, Soto-Campos G. Alvarez-Gutiérrez FJ, et al. Among authors: castilla martinez m. Open Respir Arch. 2022 Jul 2;4(3):100192. doi: 10.1016/j.opresp.2022.100192. eCollection 2022 Jul-Sep. Open Respir Arch. 2022. PMID: 37496585 Free PMC article. Spanish.
What's New in the 2022 Consensus for Severe Asthma in Adults.
Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, Martínez-Moragon E, Muñoz X, Padilla-Galo A, Perpiña-Tordera M, Soto-Campos G. Alvarez-Gutiérrez FJ, et al. Among authors: castilla martinez m. Arch Bronconeumol. 2023 Mar;59(3):190-192. doi: 10.1016/j.arbres.2022.09.012. Epub 2022 Sep 28. Arch Bronconeumol. 2023. PMID: 36243640 English, Spanish. No abstract available.
Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice.
Miralles López JC, Andújar-Espinosa R, Bravo-Gutiérrez FJ, Castilla-Martínez M, Flores-Martín I, Alemany-Francés ML, Pajarón-Fernández MJ, Mora González A, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR GROUP. Miralles López JC, et al. Among authors: castilla martinez m. J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):220-223. doi: 10.18176/jiaci.0793. Epub 2022 Feb 15. J Investig Allergol Clin Immunol. 2022. PMID: 35166673 Free article. No abstract available.
Is COVID-19 a turning point for the health workforce?
Aith F, Castilla Martínez M, Cho M, Dussault G, Harris M, Padilla M, Murphy GT, Tomlin P, Valderas JM. Aith F, et al. Among authors: castilla martinez m. Rev Panam Salud Publica. 2020 Sep 16;44:e102. doi: 10.26633/RPSP.2020.102. eCollection 2020. Rev Panam Salud Publica. 2020. PMID: 32952532 Free PMC article. No abstract available.
Analysis of response of severe eosinophilic asthmatic patients to benralizumab.
Miralles-López JC, Andújar-Espinosa R, Bravo-Gutiérrez FJ, Castilla-Martínez M, Flores-Martín I, Alemany-Francés ML, Pajarón-Fernández MJ, Mora-González A, Cabrejos-Perotti S, El-Molaka Z, Meseguer-Arce J, Avilés-Inglés MJ, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR Group. Miralles-López JC, et al. Among authors: castilla martinez m. Allergol Immunopathol (Madr). 2022 Nov 1;50(6):163-168. doi: 10.15586/aei.v50i6.704. eCollection 2022. Allergol Immunopathol (Madr). 2022. PMID: 36335460
Early Effectiveness of Dupilumab in Patients With Type 2 Severe Asthma: A Prospective Real-Life Study.
Castilla-Martínez M, Andújar-Espinosa R, Flores-Martín I, Reyes Cotes MH, Cabrejos-Perotti S, Miralles-López JC, Carbonell-Martínez A, Bravo-Gutierrez FJ, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR GROUP. Castilla-Martínez M, et al. J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):126-128. doi: 10.18176/jiaci.0872. Epub 2022 Nov 24. J Investig Allergol Clin Immunol. 2023. PMID: 36420744 Free article. No abstract available.
Characteristics and treatment regimens across ERS SHARP severe asthma registries.
van Bragt JJMH, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, Canonica GW, Cao H, Chung KF, Csoma Z, Dahlén B, Davin E, Hansen S, Heffler E, Horvath I, Korn S, Kots M, Kuna P, Kwon N, Louis R, Plaza V, Porsbjerg C, Ramos-Barbon D, Richards LB, Škrgat S, Sont JK, Vijverberg SJH, Weersink EJM, Yasinska V, Wagers SS, Djukanovic R, Maitland-van der Zee AH; SHARP Clinical Research Collaboration; Members of the SHARP Clinical Research Collaboration are. van Bragt JJMH, et al. Eur Respir J. 2020 Jan 9;55(1):1901163. doi: 10.1183/13993003.01163-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31601713 Free article.
13 results